DAIC

MARCH 18, 2024

milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , The surgery was completed quickly; the patient did well in the postoperative period and was discharged with good exercise tolerance three days post-surgery.” Four ports were made for the robotic arm and a tiny 2.5 from 2022 to 2031.

Innovation 105

Innovation Bicuspid/Mitral Exercise Technology 105

DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. JenaValve presented positive results of its U.S.

Innovation 98

Innovation Aortic valve Aortic CMS 98

DAIC

JULY 15, 2024

Getty Images mtaschetta-millane Mon, 07/15/2024 - 11:06 July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd. , Edwards’ SAPIEN M3 remains on track to become the first approved transfemoral TMVR system in Europe by the end of 2025.

Bicuspid/Mitral 105

Bicuspid/Mitral Tricuspid Technology Innovation 105